| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2075 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1494 | 2018 |
| ABT-450/r–ombitasvir and dasabuvir with or without ribavirin for HCV P Ferenci, D Bernstein, J Lalezari, D Cohen, Y Luo, C Cooper, E Tam, ... New England Journal of Medicine 370 (21), 1983-1992, 2014 | 1000 | 2014 |
| Клинические рекомендации Российской гастроэнтерологической ассоциации и ассоциации колопроктологов России по диагностике и лечению болезни Крона Р Статья Колопроктология, 7-29, 2017 | 759 | 2017 |
| Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F SE Livingston, JP Simonetti, BJ McMahon, LR Bulkow, KJ Hurlburt, ... The Journal of infectious diseases 195 (1), 5-11, 2007 | 310 | 2007 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 308 | 2022 |
| The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm–volume 2 A Hatzakis, V Chulanov, AC Gadano, C Bergin, Z Ben‐Ari, J Mossong, ... Journal of viral hepatitis 22, 26-45, 2015 | 247* | 2015 |
| Рекомендации по диагностике и лечению взрослых больных гепатитом C НД Ющук, ВТ Ивашкин, КВ Жданов, ОО Знойко, ЕА Климова, ... Типография «Буки Веди», 2013 | 200* | 2013 |
| Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19) ЕГ Камкин ЕГ Камкин.–2020.–226 с, 2020 | 189 | 2020 |
| Гепатит С в России: эпидемиологическая характеристика и пути совершенствования диагностики и надзора НН Пименов, ВП Чуланов, СВ Комарова, ИВ Карандашова, ... Эпидемиология и инфекционные болезни, 4-10, 2012 | 173 | 2012 |
| Glecaprevir/pibrentasvir for 8 weeks in treatment-naive patients with chronic HCV genotypes 1–6 and compensated cirrhosis: the EXPEDITION-8 trial RS Brown Jr, M Buti, L Rodrigues, V Chulanov, WL Chuang, H Aguilar, ... Journal of hepatology 72 (3), 441-449, 2020 | 157 | 2020 |
| Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 2 V Saraswat, S Norris, RJ De Knegt, JF Sanchez Avila, M Sonderup, ... Journal of viral hepatitis 22, 6-25, 2015 | 142 | 2015 |
| Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in combination with PEG-interferon Alpha 2a in patients … H Wedemeyer, K Schöneweis, PO Bogomolov, V Voronka, V Chulanov, ... J Hepatol 70 (Suppl 1), e81, 2019 | 129 | 2019 |
| Prevalence of HBV genotypes in Central and Eastern Europe K Deterding, I Constantinescu, FD Nedelcu, J Gervain, V Nĕmeček, ... Journal of medical virology 80 (10), 1707-1711, 2008 | 104 | 2008 |
| Dead Cas systems: types, principles, and applications S Brezgin, A Kostyusheva, D Kostyushev, V Chulanov International journal of molecular sciences 20 (23), 6041, 2019 | 102 | 2019 |
| Strategies to manage hepatitis C virus (HCV) infection disease burden–volume 2 E Gane, D Kershenobich, C Seguin‐Devaux, P Kristian, I Aho, O Dalgard, ... Journal of viral hepatitis 22, 46-73, 2015 | 91 | 2015 |
| Распространенность и клинические аспекты пищевода Барретта у населения Восточной Сибири НН Буторин, ТБ Бичурина, ВВ Цуканов, ЭВ Каспаров, ДВ Куклин, ... Терапевтический архив 85 (1), 62-65, 2013 | 78* | 2013 |
| 48 weeks of high dose (10 mg) bulevirtide as monotherapy or with peginterferon alfa-2a in patients with chronic HBV/HDV co-infection H Wedemeyer, K Schöneweis, PO Bogomolov, V Chulanov, T Stepanova, ... Journal of Hepatology 73, S52-S53, 2020 | 76 | 2020 |
| Хронический гепатит С как проблема здравоохранения России сегодня и завтра ВП Чуланов, НН Пименов, НА Мамонова, ОИ Сагалова, ИВ Шестакова, ... Терапевтический архив 87 (11), 5-10, 2015 | 76* | 2015 |
| CRISPR-Cas systems for diagnosing infectious diseases A Kostyusheva, S Brezgin, Y Babin, I Vasilyeva, D Glebe, D Kostyushev, ... Methods 203, 431-446, 2022 | 75 | 2022 |
Heiner WedemeyerDept. oGastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical SchoolEmail verificata su mh-hannover.de
